SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-109044
Filing Date
2021-04-07
Accepted
2021-04-07 17:25:16
Documents
2
Group Members
CHART WESTCOTTIKARIAN HEALTHCARE FUND GP, L.P.IKARIAN HEALTHCARE MASTER FUND, L.P.NEIL SHAHRESTANI

Document Format Files

Seq Description Document Type Size
1 SC 13G d142726dsc13g.htm SC 13G 105293
2 EX-99.1 d142726dex991.htm EX-99.1 8924
  Complete submission text file 0001193125-21-109044.txt   115959
Mailing Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104
Business Address 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Subject) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87213 | Film No.: 21813080
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201
Business Address 100 CRESCENT COURT SUITE 1620 DALLAS TX 75201 214-364-2883
Ikarian Capital, LLC (Filed by) CIK: 0001778253 (see all company filings)

IRS No.: 473466768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G